A Comparative Analysis: Selenium Sulfide vs Ketoconazole in Seborrheic Dermatitis and Dandruff

Seborrheic dermatitis is a prevalent inflammatory skin condition characterized by papulosquamous lesions, primarily affecting areas abundant in sebaceous glands, such as the scalp, face, and body folds. (1) Managing seborrheic dermatitis effectively is crucial for patient comfort and overall well-being. According to guidelines by Danish Society of Dermatology, Selenium Sulfide and Ketoconazole are recommended as first-line treatment for this condition. (2) Selenium sulfide acts through multiple pathways, including the activation of reactive oxygen species (ROS), which disrupt fungal metabolism and lead to cell death. (3) In contrast, Ketoconazole targets fungal cell membranes by inhibiting ergosterol synthesis. (4) This distinction underscores Selenium sulfide's broader spectrum of action compared to Ketoconazole's more focused antifungal activity. Given their prominence in treatment protocols, it is crucial to evaluate the comparative efficacy and safety of these molecules to help clinicians to make an informed choice.

Efficacy in Treating Seborrheic Dermatitis and Dandruff

Ketoconazole and Selenium Sulfide are both effective in managing dandruff and seborrheic dermatitis, although their mechanisms differ. Ketoconazole, known for its potent antifungal properties, is particularly effective in severe cases of dandruff and often takes precedence in treating seborrheic dermatitis due to its ability to significantly reduce redness, itching, and flaking. (5,6) Ketoconazole is also effective in treating tinea versicolor due to its ability to penetrate the skin and eradicate fungi, making it the preferred treatment. (7) is generally well- tolerated, but it may cause side effects such as itching, irritation, and a dry or oily scalp, with rare allergic reactions like rash, swelling, or difficulty in breathing. (8) Its long-term use should be monitored to prevent systemic absorption and liver toxicity, although such cases are rare with topical formulations. (9)

On the other hand, Selenium Sulfide excels at reducing scalp oiliness, a significant factor in dandruff formation. It is also effective in treating seborrheic dermatitis and is usually considered for patients who do not respond to Ketoconazole. (10,11) Selenium Sulfide is also used in the treatment of tinea versicolor. (12) Potential side effects of Selenium sulfide include scalp irritation, oiliness or dryness of hair and scalp, and an unusual oily smell but these side effects are generally mild and less frequent compared to Ketoconazole. Although improved formulations have significantly reduced issues with the oily smell and dry hair, making Selenium Sulfide a more user-friendly option for long-term use. (13,14)

Various studies were also conducted to compare the efficacy of selenium sulfide and ketoconazole. A clinical study involved 40 patients with pityriasis versicolor, who were treated with either 2% ketoconazole shampoo or 2.5% selenium sulfide shampoo, applied once a week for three weeks. In the selenium sulfide group, 17 out of 20 patients (85%) were cured, only one had mild residual disease, and two had considerable residual disease. The study concluded that there was no significant difference in the effectiveness of selenium sulfide compared to ketoconazole treatment. (15)

Comparative Safety and Adverse Reactions

A study was conducted to compare the efficacy and safety of 1.8% selenium sulfide shampoo and 2% ketoconazole shampoo in treating pityriasis versicolor (PV), a common superficial fungal infection caused by Malassezia species. This double-blind, randomized clinical trial included 100 subjects aged 12-60 with PV from Jakarta, Indonesia. Participants were randomly assigned to receive either 1.8% selenium sulfide or 2% ketoconazole shampoo. The shampoos were applied daily to the whole body for 10 minutes before rinsing, with the treatment duration ranging from 7 to 14 days based on the patients' responses.

Efficacy was evaluated through mycological examination, specifically looking for negative KOH – Parker Blue-Black® smear results. Safety was assessed by monitoring subjective and objective side effects. On the 7th day, 54% of the Selenium Sulfide group showed negative mycological results, which increased to 86% by day 14. There was no significant difference found in efficacy between Selenium Sulfide and Ketoconazole treatments. Side effects were more frequent in the ketoconazole group, with 22% experiencing issues on day 7 compared to 8% in the selenium sulfide group. By day 14th, 13% of the selenium group and 21.4% of the ketoconazole group reported side effects. The study concluded that there were no significant differences in efficacy and side effects between the two shampoos. It suggested that 1.8% selenium sulfide shampoo could be a viable, economical alternative for treating PV, with minimal side effects, making it suitable for maintenance therapy in chronic recurrent cases. Further research is recommended to optimize treatment durations and application methods for PV. (16)

Thus, while both agents are effective in treating conditions like pityriasis versicolor and seborrheic dermatitis, selenium sulfide is often noted for its lower incidence of adverse reactions. (17) Patients using selenium sulfide report fewer side effects, such as itching, irritation, and dryness, which makes it a safer option for long-term use. This tolerability is especially important for individuals with chronic conditions requiring prolonged treatment or maintenance therapy. In contrast, ketoconazole, despite its potent antifungal properties and effectiveness, has a higher likelihood of causing skin irritation and other adverse reactions, particularly with prolonged use. These side effects can include redness, burning sensations, and, in rare cases, more severe allergic reactions such as swelling and difficulty breathing. Additionally, there are concerns about systemic absorption leading to potential liver toxicity (9) and development of ketoconazole resistance (18) with long-term use of ketoconazole, even though these issues are rare with topical formulations.

Conclusion

In conclusion, both Selenium Sulfide and Ketoconazole are highly effective first-line treatments for seborrheic dermatitis, each with unique advantages. While Ketoconazole's potent antifungal properties make it superior for severe cases and certain fungal skin infections, Selenium Sulfide offers a safer profile with fewer adverse reactions, making it an excellent option for patients requiring long-term management. Recent studies have also identified Malassezia species with resistance to azole antifungals, potentially due to increased prophylactic use of azoles, prolonged treatment regimens, or long-term use of low-dose azoles. (18,19) This resistance highlights Selenium Sulfide as a more apt or better choice of treatment in these cases. Given their comparable efficacy, safety and resistance dermatologists can select either agent based on individual patient response and personal preferences. The current body of evidence is limited, and further head-to-head studies and real-world evidence are recommended to provide more comprehensive guidance on the optimal use of these treatments.

For the use of a registered medical practitioner or a hospital or a laboratory only

IND2327692 02 Sep 2024

References:

1. Heath CR, Usatine RP. Seborrheic dermatitis. J Fam Pract [Internet]. 2021 Nov 1 [cited 2024 Jun 19];70(9):E3–4. Available from: https://pubmed.ncbi.nlm.nih.gov/34818158/

2. View of Evidence-based Danish Guidelines for the Treatment of Malassezia-related Skin Diseases [Internet]. [cited 2024 Jun 19]. Available from: https://medicaljournalssweden.se/actadv/article/view/5601/8495

3. Barchielli G, Capperucci A, Tanini D. The Role of Selenium in Pathologies: An Updated Review. Antioxidants [Internet]. 2022 Feb 1 [cited 2024 Jul 12];11(2). Available from: /pmc/articles/PMC8868242/

4. Ghannoum MA, Rice LB. Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance. Clin Microbiol Rev [Internet]. 1999 [cited 2024 Jul 12];12(4):501. Available from: /pmc/articles/PMC88922/

5. Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol [Internet]. 1995 [cited 2024 Jun 19];132(3):441–5. Available from: https://pubmed.ncbi.nlm.nih.gov/7718463/

6. del Rosso JQ. Adult Seborrheic Dermatitis: A Status Report on Practical Topical Management. J Clin Aesthet Dermatol [Internet]. 2011 May [cited 2024 Jun 19];4(5):32. Available from: /pmc/articles/PMC3100109/

7. Gupta AK, Foley KA. Antifungal Treatment for Pityriasis Versicolor. Journal of Fungi [Internet]. 2015 Jun 1 [cited 2024 Jun 19];1(1):13. Available from: /pmc/articles/PMC5770013/

8. Chottawornsak N, Chongpison Y, Asawanonda P, Kumtornrut C. Topical 2% ketoconazole cream monotherapy significantly improves adult female acne: A double-blind, randomized placebo-controlled trial. J Dermatol [Internet]. 2019 Dec 1 [cited 2024 Jun 19];46(12):1184–9. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/1346-8138.15113

9. Ketoconazole. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. 2017 May 17 [cited 2024 Jun 20]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK547869/

10. Borda LJ, Wikramanayake TC. Seborrheic Dermatitis and Dandruff: A Comprehensive Review. J Clin Investig Dermatol [Internet]. 2015 [cited 2024 Jun 20];3(2). Available from: /pmc/articles/PMC4852869/

11. Godse G, Godse K. Safety, Efficacy and Attributes of 2.5% Selenium Sulfide Shampoo in the Treatment of Dandruff: A Single-Center Study. Cureus [Internet]. 2024 Mar 29 [cited 2024 Jun 20];16(3). Available from: /pmc/articles/PMC11055963/

12. Sánchez JL, Torres VM. Double-blind efficacy study of selenium sulfide in tinea versicolor. J Am Acad Dermatol [Internet]. 1984 [cited 2024 Jun 20];11(2 Pt 1):235–8. Available from: https://pubmed.ncbi.nlm.nih.gov/6384285/

13. Choulis NH. Miscellaneous Drugs, Materials, Medical Devices and Techniques. Side Effects of Drugs Annual. 2014 Jan 1;36:725–46.

14. Ranganathan S, Mukhopadhyay T. DANDRUFF: THE MOST COMMERCIALLY EXPLOITED SKIN DISEASE. Indian J Dermatol [Internet]. 2010 Apr 1 [cited 2024 Jun 20];55(2):130. Available from: /pmc/articles/PMC2887514/

15. Nagpal VB, Jain VK, Aggarwal K. Comparative study of oral and topical ketoconazole therapy in pityriasis versicolor. Indian J Dermatol Venereol Leprol [Internet]. 2003 [cited 2024 Jun 20];69(4):287–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17642914

16. Lusiana, Surachmiati L, Saldi SRF, Lusianingtyas T, Bramono K. The mycological efficacy and safety of selenium sulfide 1.8% versus ketoconazole 2% shampoo in pityriasis versicolor: A double-blind randomized controlled trial. Germs [Internet]. 2022 [cited 2024 Jun 20];12(4):452. Available from: /pmc/articles/PMC10660221/

17. Lusiana, Surachmiati L, Saldi SRF, Lusianingtyas T, Bramono K. The mycological efficacy and safety of selenium sulfide 1.8% versus ketoconazole 2% shampoo in pityriasis versicolor: A double-blind randomized controlled trial. Germs [Internet]. 2022 [cited 2024 Jul 12];12(4):452. Available from: /pmc/articles/PMC10660221/

18. Leong C, Chan JWK, Lee SM, Lam YI, Goh JPZ, Ianiri G, et al. Azole resistance mechanisms in pathogenic M. furfur. Antimicrob Agents Chemother [Internet]. 2021 May 1 [cited 2024 Jun 20];65(5). Available from: https://pubmed.ncbi.nlm.nih.gov/33619053/

19. Park M, Cho YJ, Lee YW, Jung WH. Genomic Multiplication and Drug Efflux Influence Ketoconazole Resistance in Malassezia restricta. Front Cell Infect Microbiol [Internet]. 2020 Apr 30 [cited 2024 Jun 20];10:191. Available from: /pmc/articles/PMC7203472/